Otros Nombres
CaperaseCATCatalase-peroxidaseEC 1.11.1.6EquilaseH2O2:H2O2 oxidoreductaseHaem catalaseHeme catalaseHydrogen peroxide oxidoreductaseHydrogen-peroxide:hydrogen-peroxide oxidoreductaseHydroperoxidaseManganese catalaseOptidase
RaÃz de kava (Piper methysticum) es una planta tropical nativa del PacÃfico Sur, especialmente de Vanuatu, Fiji y Tonga, donde ha sido utilizada durante siglos en ceremonias tradicionales y reuniones sociales. Los compuestos activos del kava, conocidos como kavalactonas, incluyen metisticina, kavaÃna, dihidrokavaÃna y yangonina, que son responsables de sus efectos relajantes, ansiolÃticos (contra la ansiedad) y sedantes leves.
La raÃz de kava es mejor conocida por su capacidad para promover la relajación, reducir la ansiedad y mejorar el estado de ánimo sin deteriorar la claridad mental. Se utiliza comúnmente como una alternativa natural a los ansiolÃticos farmacéuticos o antidepresivos. El kava también ha sido utilizado tradicionalmente para tratar el insomnio, la tensión muscular y el estrés, y a veces se consume para mejorar el vÃnculo social y el bienestar espiritual.
El kava está disponible en forma de cápsula, tableta, tintura o té, y se utiliza tÃpicamente para aliviar la tensión, mejorar la calidad del sueño y promover el equilibrio emocional.
Uso Histórico
El kava tiene una profunda significación cultural en las Islas del PacÃfico, donde ha sido utilizado durante más de 3,000 años. La raÃz se machaca o ralla tradicionalmente, se mezcla con agua y se consume en tazones ceremoniales de kava. La bebida es una parte central de los rituales sociales, religiosos y comunitarios, utilizada frecuentemente para promover la relajación, la mejora del estado de ánimo y la conexión espiritual.
En la medicina tradicional de los isleños del PacÃfico, el kava se utilizaba para tratar una variedad de dolencias, incluyendo ansiedad, estrés, dolor muscular y trastornos del sueño. También se creÃa que tenÃa cualidades purificadoras y protectoras. El consumo de kava en rituales estaba frecuentemente vinculado con la purificación del cuerpo y la mente antes de eventos importantes o ceremonias espirituales.
En el mundo occidental, el uso del kava como remedio natural para la ansiedad y los trastornos del sueño se popularizó a finales del siglo XX, con un creciente interés en sus propiedades no adictivas y su efectividad en comparación con medicamentos convencionales como las benzodiazepinas.
Hoy en dÃa, el kava se utiliza comúnmente como una alternativa natural para reducir el estrés, mejorar la relajación y promover el bienestar emocional, aunque su uso ha sido regulado en algunos paÃses debido a preocupaciones sobre sus posibles efectos en la salud del hÃgado. Sin embargo, cuando se utiliza de manera responsable y con moderación, el kava sigue siendo un remedio herbal popular y efectivo para el manejo de la ansiedad y el estrés.
Condiciones de salud que catalasa puede ayudar a apoyar.
Catalase is one of the most important enzymatic antioxidants in aerobic organisms, catalyzing the decomposition of hydrogen peroxide (Hâ‚‚Oâ‚‚) into water and oxygen. It works in concert with superoxide dismutase and glutathione peroxidase to neutralize reactive oxygen species (ROS). Deficiency or malfunction of catalase is linked to the pathogenesis of numerous oxidative stress-related diseases.
Catalase activity in bronchoalveolar lavage (BAL) fluid is reduced in asthma patients compared to healthy controls, due to oxidative inactivation by peroxynitrite and other RNS. Asthma is associated with a global decrease in antioxidant defenses including catalase, superoxide dismutase, and glutathione, contributing to airway inflammation and remodeling.
Reduced catalase activity is documented across multiple autoimmune conditions including vitiligo, rheumatoid arthritis, and IBD. Oxidative stress driven by Hâ‚‚Oâ‚‚ accumulation is a shared pathogenic mechanism in autoimmune diseases, where catalase deficiency amplifies tissue damage and immune dysregulation.
CAT gene mutations and reduced catalase activity are associated with diabetes mellitus and insulin resistance. Catalase glycation—the non-enzymatic modification of the enzyme in hyperglycemic conditions—impairs its function, worsening β-cell oxidative stress. Acatalasemia (inherited catalase deficiency) is associated with an increased risk of type 2 diabetes.
Catalase is implicated in chronic inflammation through its role in controlling H₂O₂ levels, a key ROS involved in modulating inflammatory signaling pathways including NF-κB. Reduced catalase activity is observed in multiple chronic inflammatory diseases. ROS accumulation due to low catalase activity promotes lipid peroxidation, protein aggregation, and sustained inflammatory cascades.
Mitochondria-targeted catalase overexpression in aged mice improves neurovascular coupling and cerebral blood flow, protecting against age-related cognitive decline. Catalase glycation in Alzheimer's disease and aging accelerates neuronal degeneration and impairs mitochondrial homeostasis.
Catalase activity is an established biomarker of oxidative stress caused by environmental toxin exposure. Studies document that heavy metal exposure (particularly lead) suppresses catalase activity and is associated with elevated blood pressure and organ damage. Catalase gene polymorphisms modulate susceptibility to lead-induced oxidative injury.
Catalase maintains hair follicle redox balance by clearing Hâ‚‚Oâ‚‚, which if left to accumulate damages follicular melanocytes and disrupts normal hair cycling. Reduced catalase activity is associated with follicular oxidative stress that can impair both pigmentation and the anagen (growth) phase of the hair cycle.
Reduced catalase activity in scalp hair follicles leads to millimolar accumulation of Hâ‚‚Oâ‚‚, which bleaches hair from within and disrupts melanin synthesis. This mechanism underlies both age-related hair graying and is associated with androgenic alopecia. A pseudocatalase compound has been trialed in vitiligo and gray hair reversal.
Catalase deficiency is postulated to contribute to the pathogenesis of many age-associated degenerative diseases. Landmark transgenic mouse studies demonstrated that mitochondria-targeted catalase overexpression extended median and maximal lifespan by approximately 20%. Catalase activity declines with age, contributing to increased ROS accumulation in aging tissues.
Catalase activity in erythrocytes and immune cells is significantly reduced in active IBD (both Crohn's disease and ulcerative colitis) compared to healthy controls, as confirmed by a systematic review and meta-analysis. Catalase has diagnostic utility as a biomarker of IBD activity, with activity inversely correlating with disease severity.
Mitochondria-targeted catalase is a well-studied model for combating mitochondrial oxidative stress. MCAT transgenic mice show extended lifespan and protection from age-related cardiac decline, linking mitochondrial Hâ‚‚Oâ‚‚ clearance to mitochondrial health. Catalase glycation in metabolic disease impairs mitochondrial homeostasis.
Catalase activity is consistently reduced in the blood of Parkinson's disease (PD) patients compared to controls, as confirmed by multiple meta-analyses. The substantia nigra in PD is under intense oxidative stress, and H₂O₂—the direct substrate of catalase—is generated in excess through dopamine metabolism. Experimental catalase mimetics show neuroprotective properties in animal models.
Studies of erythrocyte and synovial antioxidant enzyme activity in rheumatoid arthritis (RA) patients document altered catalase activity alongside elevated oxidative stress markers. Oxidative stress is a well-recognized pathogenic driver in RA, with ROS amplifying joint inflammation and cartilage destruction.
Catalase activity in the dermis declines with chronological aging, contributing to Hâ‚‚Oâ‚‚ accumulation that alters MAP kinase signaling and promotes skin senescence. ROS-driven oxidative stress is a principal mechanism of both chronological and photoaging, and catalase is a key enzymatic defense against this process.
Catalase deficiency in vitiliginous epidermis is central to vitiligo pathogenesis: low catalase allows H2O2 to accumulate and destroy melanocytes. Topical pseudocatalase preparations have been tested in multiple clinical studies to restore catalase-like activity and promote repigmentation, though results have been inconsistent. Catalase is a key mechanistic target for antioxidant-based vitiligo therapies.
Sistemas corporales que catalasa puede ayudar a apoyar.